2683-70-7

Usage

Uses

Used in Pharmaceutical Industry:
4-(PhenoxyMethyl)Benzaldehyde is used as a key intermediate in the synthesis of various pharmaceuticals for its potential therapeutic applications, contributing to the development of new drugs.
Used in Perfumery:
In the perfume industry, 4-(PhenoxyMethyl)Benzaldehyde is used as a fragrance ingredient, leveraging its strong, sweet, floral scent to enhance the aroma of perfumes and other scented products.
Used in Food Industry:
4-(PhenoxyMethyl)Benzaldehyde is used as a flavoring agent in the food industry, adding unique flavor profiles to various food products.
Used in Cosmetics Industry:
This chemical compound is also used in the cosmetics industry as a fragrance ingredient, providing a pleasant scent to a range of cosmetic products.
Used in Dye and Resin Production:
4-(PhenoxyMethyl)Benzaldehyde is utilized in the production of dyes and resins, contributing to the coloration and binding properties of these materials.
Used in Organic Compounds Synthesis:
It is employed in the synthesis of other organic compounds, serving as a versatile building block in organic chemistry for creating a variety of molecules with different applications.

Upstream product

• 4394-85-8 4-morpholinecarboxaldehyde 
• 20600-22-0 1-bromo-4-(phenoxymethyl)benzene 
• 108-95-2 phenol 
• 68-12-2 N,N-dimethyl-formamide 
• 589-15-1 1-bromomethyl-4-bromobenzene 

Downstream Products

• 1339882-18-6 C₂₂H₁₈O₃ 
• 1339882-53-9 C₂₂H₁₆O₃ 

Relevant academic research and scientific papers

Design, synthesis, and biological evaluation of pyrimidine analogs as SecA inhibitors

SecA, a key component of the bacterial Sec-dependent secretion pathway, is an attractive target for the development of new antimicrobial agents. We have previously reported pyrimidine analogs as SecA inhibitors. Herein, we report an extension of the earlier work in the synthesis and evaluation of a series of 15 5-cyanothiouracil derivatives as SecA inhibitors. All the compounds have been evaluated for their inhibition of SecA ATPase (EcSecAN68) and for their antimicrobial activity against Escherichia coli NR698 (a leaky mutant) and Bacillus anthracis Sterne. Twelve compounds showed IC50 of less than 6.3 μM when tested against EcSecAN68. In antimicrobial studies against E. coli NR698, six compounds showed MIC of 12.5 μM with three being less than 6.3 μM. Against B. anthracis Sterne, three compounds showed MIC of 6.3 μM.

2-(HETERO)ARYL-BENZIMIDAZOLE AND IMIDAZOPYRIDINE DERIVATIVES AS INHIBITORS OF ASPARAGIME EMETHYL TRANSFERASE

Substituted benzimidazole and 3H-imidazo[4,5-b]pyridines or formula I: where X and Y respectively are selected from: (i) N and N; and (ii) N and CR4; A2 is selected from:, a C5 heteroarylene group, containing 2 or 3 ring heteroatoms, where the bonds to L1 and the core are β to one another; L1 is selected from: (i)A1-O-CH2-A2; (ii)A1-CH2-O-A2; (iii)A1-C(=O)-NH-A2; (iv)A1-CH(OH)-A2; (v)A1-CH2-NH-C(=O)-A2; (vi) A1-S-CH2-A2; (vii)A1- CH2-S-A2; (viii)A1-CH2-A2; and (ix)A1-CH(CH3)-O-A2; A1 is phenyl, optionally substituted by F or CF3; their use as pharmaceuticals, and in particular, in treating cancer and hemoglobinopathies.

NOVEL PROTEIN TYROSINE PHOSPHATASE - IB INHIBITORS

The present invention relates to the novel compounds of the general formula (I), wherein the symbols are same as described in specification, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, to process and intermediates for the preparation of the above said compounds, having the utility of these compounds in medicine and to methods for their therapeutic use, and their use in the treatment of metabolic disorders.